Michelle Brennan
Director/Board Member bij CARDINAL HEALTH, INC.
Vermogen: 592 262 $ op 29-02-2024
Profiel
Currently, Michelle Brennan is Advisor at Tau Ventures LLC.
Ms. Brennan is also on the board of Cardinal Health, Inc., Masimo Corp.
and Perosphere Technologies, Inc.
Ms. Brennan previously held the position of Member of Life Sciences Council, Chairman of MedTech Europe and Group Chairman-EMEA Medical Devices at Johnson & Johnson Foundation Scotland.
Michelle Brennan received an undergraduate degree from the University of Kansas.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
CARDINAL HEALTH, INC.
0.00% | 15-11-2023 | 5 289 ( 0.00% ) | 592 262 $ | 29-02-2024 |
Actieve functies van Michelle Brennan
Bedrijven | Functie | Begin |
---|---|---|
CARDINAL HEALTH, INC. | Director/Board Member | 06-09-2022 |
MASIMO CORPORATION | Director/Board Member | 26-06-2023 |
Tau Ventures LLC
Tau Ventures LLC Investment ManagersFinance Tau Ventures LLC (Tau Ventures) is a venture capital firm founded in 2018 by Amit Garg and Sanjay K. Rao. The firm is headquartered in Palo Alto, California. | Consultant / Advisor | - |
Perosphere Technologies, Inc.
Perosphere Technologies, Inc. Packaged SoftwareTechnology Services Perosphere Technologies, Inc. is a private medical technologies company that is focused on developing and commercializing the novel POC (point-of-care) coagulometer. The company is based in Danbury, CT. This diagnostic tool informs diagnosis, treatment, and prevention through precision data, made immediately accessible to all. The POC coagulometer is the only point-of-care diagnostic tool that effectively and swiftly tests clotting times across drug classes, including direct oral anticoagulants (DOACs). The fast diagnosis and related appropriate treatment decisions the POC coagulometer enables will help establish a new standard of care in hospital emergency departments for patients at risk for bleeding and has the potential to improve efficiency, provide significant cost savings, and better patient outcomes. The CEO of the company is Sasha H. Bakhru. | Director/Board Member | 02-08-2023 |
Eerdere bekende functies van Michelle Brennan
Bedrijven | Functie | Einde |
---|---|---|
COUPA SOFTWARE INCORPORATED | Director/Board Member | 28-02-2023 |
Life Sciences Council | Corporate Officer/Principal | 01-01-2020 |
Johnson & Johnson Foundation Scotland
Johnson & Johnson Foundation Scotland Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Foundation Scotland was founded in 2007. The British company's description is unrelated to their actual business. | Director/Board Member | - |
MedTech Europe | Chairman | - |
Opleiding van Michelle Brennan
University of Kansas | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
CARDINAL HEALTH, INC. | Distribution Services |
MASIMO CORPORATION | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Coupa Software, Inc.
Coupa Software, Inc. Packaged SoftwareTechnology Services Coupa Software, Inc. engages in the provision of business spend management (BSM) solutions. Its products include invoice, expense, pay, spend analysis, strategic sourcing, contract management contingent workforce, and supplier management. The company was founded by Noah Eisner and Dave Stephens in 2006 and is headquartered in San Mateo, CA. | Technology Services |
Johnson & Johnson Foundation Scotland
Johnson & Johnson Foundation Scotland Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Foundation Scotland was founded in 2007. The British company's description is unrelated to their actual business. | Commercial Services |
MedTech Europe | |
Perosphere Technologies, Inc.
Perosphere Technologies, Inc. Packaged SoftwareTechnology Services Perosphere Technologies, Inc. is a private medical technologies company that is focused on developing and commercializing the novel POC (point-of-care) coagulometer. The company is based in Danbury, CT. This diagnostic tool informs diagnosis, treatment, and prevention through precision data, made immediately accessible to all. The POC coagulometer is the only point-of-care diagnostic tool that effectively and swiftly tests clotting times across drug classes, including direct oral anticoagulants (DOACs). The fast diagnosis and related appropriate treatment decisions the POC coagulometer enables will help establish a new standard of care in hospital emergency departments for patients at risk for bleeding and has the potential to improve efficiency, provide significant cost savings, and better patient outcomes. The CEO of the company is Sasha H. Bakhru. | Technology Services |
Tau Ventures LLC
Tau Ventures LLC Investment ManagersFinance Tau Ventures LLC (Tau Ventures) is a venture capital firm founded in 2018 by Amit Garg and Sanjay K. Rao. The firm is headquartered in Palo Alto, California. | Finance |
Life Sciences Council |